Eli Lilly 2015 Annual Report Download - page 78
Download and view the complete annual report
Please find page 78 of the 2015 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68 -
69 -
70 -
71 -
72 -
73 -
74 -
75 -
76 -
77 -
78 -
79 -
80 -
81 -
82 -
83 -
84 -
85 -
86 -
87 -
88 -
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
 |
 |
F66
FINANCIAL REPORT
During the next 12 months, we expect to reclassify from accumulated other comprehensive loss to earnings
$14.8 million of pretax net losses on cash flow hedges of the variability in expected future interest payments
on our floating rate debt.
Fair Value of Financial Instruments
The following tables summarize certain fair value information at December 31 for assets and liabilities
measured at fair value on a recurring basis, as well as the carrying amount and amortized cost of certain
other investments:
Fair Value Measurements Using
Description
Carrying
Amount Cost (1)
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Fair
Value
December 31, 2015
Cash equivalents $ 1,644.4 $ 1,644.4 $ 1,637.0 $ 7.4 $ — $ 1,644.4
Short-term investments:
U.S. government and agency
securities $153.2 $153.4 $ 153.2 $ — $ — $ 153.2
Corporate debt securities 625.8 626.9 — 625.8 — 625.8
Asset-backed securities 3.3 3.3 — 3.3 — 3.3
Other securities 3.1 3.1 — 3.1 — 3.1
Short-term investments $ 785.4 $ 786.7
Noncurrent investments:
U.S. government and agency
securities $284.5 $286.0 $ 283.5 $ 1.0 $ — $ 284.5
Corporate debt securities 1,962.6 1,995.8 — 1,962.6 — 1,962.6
Mortgage-backed securities 153.3 154.7 — 153.3 — 153.3
Asset-backed securities 441.9 443.1 — 441.9 — 441.9
Other securities 4.1 4.1 — 4.1 — 4.1
Marketable equity securities 128.9 74.8 128.9 — — 128.9
Other investments(2) 671.3 671.3
Noncurrent investments $ 3,646.6 $ 3,629.8
December 31, 2014
Cash equivalents $ 2,443.5 $ 2,443.5 $ 2,415.5 $ 28.0 $ — $ 2,443.5
Short-term investments:
U.S. government and agency
securities $185.5 $185.6 $ 156.5 $ 29.0 $ — $ 185.5
Corporate debt securities 767.4 766.7 — 767.4 — 767.4
Other securities 2.5 2.5 — 2.5 — 2.5
Short-term investments $ 955.4 $ 954.8
Noncurrent investments:
U.S. government and agency
securities $756.7 $757.5 $ 747.5 $ 9.2 $ — $ 756.7
Corporate debt securities 2,462.7 2,468.9 — 2,462.7 — 2,462.7
Mortgage-backed securities 217.0 217.6 — 217.0 — 217.0
Asset-backed securities 477.8 478.0 — 477.8 — 477.8
Other securities 3.2 3.2 — 3.2 — 3.2
Marketable equity securities 204.8 44.0 204.8 — — 204.8
Other investments(2) 446.7 446.7
Noncurrent investments $ 4,568.9 $ 4,415.9
(1) For available-for-sale debt securities, amounts disclosed represent the securities' amortized cost.
(2) Primarily includes investments accounted for under the cost method and equity method for which fair value disclosures are not
applicable.